The combination of toripalimab, nimotuzumab, and chemotherapy showed “promising antitumor activity with acceptable toxicity,” researchers wrote.

CAR T-cell therapy showed encouraging efficacy and good safety in newly diagnosed Ph-positive ALL,” the researchers wrote.

This move is the latest in a series of attempts by the Trump administration to eliminate DEI/DEIA programs and reduce NIH funding.

Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.

Progress has been made in reducing overall cancer mortality, largely driven by sustained declines in lung cancer,” the researchers wrote.

The 3-year overall survival rate was 89.1% for patients who omitted ET and 92.3% for patients who received ET. Omitting adjuvant endocrine therapy (ET) can increase the risk of death in patients ...

Firings at the HHS included the entire office that sets federal poverty guidelines, which determine whether Americans are eligible for programs such as Medicaid.

Cancer apps can provide patients with helpful tools, but there are risks associated with these apps, according to experts.

The Trump administration is weighing a plan to cut nearly a third of the federal health budget, according to a memo obtained by CNN.

A senior government health researcher has said he is retiring early because the NIH has censored his latest findings on ultra-processed food.

Pediatric cancer patients and their caregivers largely prefer to access test results immediately through the patient portal rather than wait to hear about results from oncologists, according to survey ...